Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AISAR
Hyderabad, Telangana, Indiaaisar.io ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
AISAR (Artificial Intelligence for Synthetic and Analytical Research) is a biotechnology company that leverages advanced artificial intelligence and machine learning to accelerate the drug discovery and development process. The company focuses on identifying novel small molecule candidates across various therapeutic areas, including oncology and infectious diseases, by integrating computational modeling with synthetic chemistry. AISAR's platform aims to optimize lead identification and reduce the time and cost associated with traditional drug development cycles. By utilizing predictive analytics, the company seeks to improve the success rates of clinical candidates through better target validation and molecular design.
- Therapeutic areas
- Infectious DiseasesNeurologyOncology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on AISAR.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AISAR.